Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Connect with investors, share insights, and grow together
Stay up to date on latest investing trends and other announcements
Explore our range of financial tools to streamline your investment planning
A structured, comprehensive way to understand global investing
Read about our journey and get to know the leadership team at Vested
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering (lead drug) that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval. more
| Time Frame | BBC | S&P500 |
|---|---|---|
| 1-Week Return | -6.07% | -0.68% |
| 1-Month Return | -5.54% | -2.01% |
| 3-Month Return | 14.45% | 0.79% |
| 6-Month Return | 20.37% | 13.67% |
| 1-Year Return | 108.08% | 15.09% |
| 3-Year Return | 136.36% | 68.95% |
| 5-Year Return | 5.98% | 71.22% |
| 10-Year Return | 133.47% | 259.24% |
| Time Frame | BBC | S&P500 |
|---|---|---|
| 1-Week Return | -96.18% | -29.94% |
| 1-Month Return | -50.01% | -21.89% |
| 3-Month Return | 72.87% | 3.24% |
| 6-Month Return | 45.64% | 29.67% |
| 1-Year Return | 108.08% | 15.09% |
| 3-Year Return | 33.21% | 19.10% |
| 5-Year Return | 1.17% | 11.36% |
| 10-Year Return | 8.85% | 13.64% |
| Stock name | Ticker | Weight |
|---|---|---|
Amylyx Pharmaceuticals Inc | AMLX | 1.47% |
First Tracks Biotherapeutics Inc | TRAX | 1.44% |
AbCellera Biologics Inc | ABCL | 1.33% |
Xencor Inc | XNCR | 1.31% |
Monopar Therapeutics Inc | MNPR | 1.23% |
SELLAS Life Sciences Group Inc | SLS | 1.15% |
MBX Biosciences Inc | MBX | 1.15% |
LB Pharmaceuticals Inc | LBRX | 1.09% |
uniQure NV | QURE | 1.08% |
Zenas Biopharma Inc | ZBIO | 1.05% |
Vor BioPharma Inc | VOR | 1.04% |
Cullinan Therapeutics Inc | CGEM | 1.02% |
4D Molecular Therapeutics Inc | FDMT | 1.02% |
Definium Therapeutics Inc | DFTX | 1.02% |
Nurix Therapeutics Inc | NRIX | 1.02% |
Immix Biopharma Inc | IMMX | 1% |
Replimune Group Inc | REPL | 1% |
SpyGlass Pharma Inc | SGP | 0.99% |
Alto Neuroscience Inc | ANRO | 0.98% |
Adlai Nortye Group Ltd | ANL | 0.98% |
ORIC Pharmaceuticals Inc | ORIC | 0.97% |
Palvella Therapeutics Inc | PVLA | 0.92% |
Viridian Therapeutics Inc | VRDN | 0.91% |
Immunome Inc | IMNM | 0.91% |
Kymera Therapeutics Inc | KYMR | 0.91% |
Design Therapeutics Inc | DSGN | 0.9% |
MeiraGTx Holdings plc | MGTX | 0.89% |
Assembly Biosciences Inc | ASMB | 0.89% |
Candel Therapeutics Inc | CADL | 0.88% |
Revolution Medicines Inc | RVMD | 0.88% |
Achieve Life Sciences Inc | ACHV | 0.88% |
Oruka Therapeutics Inc | ORKA | 0.88% |
Climb Bio Inc | CLYM | 0.87% |
Janux Therapeutics Inc | JANX | 0.87% |
Ideaya Biosciences Inc | IDYA | 0.86% |
GH Research PLC | GHRS | 0.86% |
Damora Therapeutics Inc | DMRA | 0.86% |
REGENXBIO Inc | RGNX | 0.86% |
Relay Therapeutics Inc | RLAY | 0.85% |
Solid Biosciences Inc | SLDB | 0.85% |
Praxis Precision Medicines Inc | PRAX | 0.85% |
Belite Bio Inc | BLTE | 0.85% |
Rocket Pharmaceuticals Inc | RCKT | 0.84% |
Altimmune Inc | ALT | 0.84% |
Scholar Rock Holding Corp | SRRK | 0.84% |
Dianthus Therapeutics Inc | DNTH | 0.84% |
Jade Biosciences Inc | JBIO | 0.83% |
Generate Biomedicines Inc | GENB | 0.83% |
Neurogene Inc | NGNE | 0.83% |
Vaxcyte Inc | PCVX | 0.83% |
Mineralys Therapeutics Inc | MLYS | 0.83% |
Edgewise Therapeutics Inc | EWTX | 0.82% |
Vir Biotechnology Inc | VIR | 0.82% |
Pharvaris NV | PHVS | 0.82% |
Enliven Therapeutics Inc | ELVN | 0.81% |
Celldex Therapeutics Inc | CLDX | 0.81% |
Summit Therapeutics Inc | SMMT | 0.81% |
CG oncology Inc | CGON | 0.81% |
Inhibrx Biosciences Inc | INBX | 0.81% |
Prime Medicine Inc | PRME | 0.81% |
Arbutus Biopharma Corp | ABUS | 0.8% |
Nektar Therapeutics | NKTR | 0.79% |
Compass Pathways Plc | CMPS | 0.79% |
Avalo Therapeutics Inc | AVTX | 0.78% |
Sana Biotechnology Inc | SANA | 0.77% |
Arvinas Inc | ARVN | 0.77% |
Erasca Inc | ERAS | 0.76% |
Biohaven Ltd | BHVN | 0.76% |
Immunovant Inc | IMVT | 0.76% |
Rapport Therapeutics Inc | RAPP | 0.76% |
Xenon Pharmaceuticals Inc | XENE | 0.75% |
ProKidney Corp | PROK | 0.75% |
Viking Therapeutics Inc | VKTX | 0.75% |
CytomX Therapeutics Inc | CTMX | 0.74% |
Arcus Biosciences Inc | RCUS | 0.73% |
Spyre Therapeutics Inc | SYRE | 0.73% |
Prothena Corp PLC | PRTA | 0.73% |
Aktis Oncology Inc | AKTS | 0.73% |
Aura Biosciences Inc | AURA | 0.73% |
Disc Medicine Inc | IRON | 0.73% |
Crescent Biopharma Inc | CBIO | 0.72% |
Corvus Pharmaceuticals Inc | CRVS | 0.72% |
Olema Pharmaceuticals Inc | OLMA | 0.72% |
Bicara Therapeutics Inc | BCAX | 0.71% |
Lexicon Pharmaceuticals Inc | LXRX | 0.7% |
Septerna Inc | SEPN | 0.7% |
Rezolute Inc | RZLT | 0.7% |
Maze Therapeutics Inc | MAZE | 0.69% |
Cogent Biosciences Inc | COGT | 0.69% |
VeraDermics Inc | MANE | 0.68% |
Oculis Holding AG | OCS | 0.68% |
Dyne Therapeutics Inc | DYN | 0.68% |
Savara Inc | SVRA | 0.68% |
Compass Therapeutics Inc | CMPX | 0.67% |
Invivyd Inc | IVVD | 0.67% |
Recursion Pharmaceuticals Inc | RXRX | 0.67% |
Lexeo Therapeutics Inc | LXEO | 0.67% |
Intellia Therapeutics Inc | NTLA | 0.66% |
Stoke Therapeutics Inc | STOK | 0.66% |
AnaptysBio Inc | ANAB | 0.66% |
Vera Therapeutics Inc | VERA | 0.65% |
Celcuity Inc | CELC | 0.64% |
Kodiak Sciences Inc | KOD | 0.64% |
Bicycle Therapeutics PLC | BCYC | 0.63% |
Tectonic Therapeutic Inc | TECX | 0.63% |
Upstream Bio Inc | UPB | 0.63% |
ArriVent Biopharma Inc | AVBP | 0.63% |
Immatics NV | IMTX | 0.62% |
Allogene Therapeutics Inc | ALLO | 0.62% |
Structure Therapeutics Inc | GPCR | 0.61% |
Cabaletta Bio Inc | CABA | 0.61% |
Taysha Gene Therapies Inc | TSHA | 0.6% |
Annexon Inc | ANNX | 0.59% |
Tyra Biosciences Inc | TYRA | 0.58% |
Beam Therapeutics Inc | BEAM | 0.56% |
Wave Life Sciences Inc | WVE | 0.53% |
Monte Rosa Therapeutics Inc | GLUE | 0.52% |
Tango Therapeutics Inc | TNGX | 0.5% |
Newamsterdam Pharma Co NV | NAMS | 0.48% |
BridgeBio Oncology Therapeutics Inc | BBOT | 0.48% |
MoonLake Immunotherapeutics | MLTX | 0.47% |
Relmada Therapeutics Inc | RLMD | 0.41% |
Evommune Inc | EVMN | 0.36% |
MapLight Therapeutics Inc | MPLT | 0.33% |
BioAge Labs Inc | BIOA | 0.32% |
Alumis Inc | ALMS | 0.27% |
EyePoint Inc | EYPT | 0.22% |
Capricor Therapeutics Inc | CAPR | 0.21% |
Sionna Therapeutics Inc | SION | 0.14% |
Cash/Cash equivalents | Cash.Cash.equivalents | 0.08% |
| Sector | Weight |
|---|---|
|
Health care | 100.00% |
Virtus LifeSci Biotech Clinical Trials ETF (BBC) share price today is $48.536.
Yes, Indians can buy shares of Virtus LifeSci Biotech Clinical Trials ETF (BBC) on Vested. To buy BBC from India, you can open a US Brokerage account by signing up on Vested. The account opening process is completely digital and secure, and takes 3-5 minutes to complete.
Yes, you can purchase fractional shares of Virtus LifeSci Biotech Clinical Trials ETF (BBC) on Vested. You can start investing in Virtus LifeSci Biotech Clinical Trials ETF (BBC) with a minimum investment of $1.
The 52-week high price of Virtus LifeSci Biotech Clinical Trials ETF (BBC) is $56.18. The 52-week low price of Virtus LifeSci Biotech Clinical Trials ETF (BBC) is $23.72.
The stock symbol (or ticker) of Virtus LifeSci Biotech Clinical Trials ETF is BBC.
Yes, you can setup SIP in Virtus LifeSci Biotech Clinical Trials ETF shares. Follow the below steps to create the SIP:
Here is the historical performance of BBC on the Vested app.
The expense ratio of Virtus LifeSci Biotech Clinical Trials ETF (BBC) is 0.79%.
Link copied